In mouse breast cancer cells, IFT20 inhibits epithelial mesenchymal transition and cell migration [56], while in human osteosarcoma and colorectal cancer cells, it promotes invadopodia formation and tumor invasiveness [66,67]. This evidence concerns the gene IFT20 and breast carcinoma.